Precision Oncology and the New Era of Lung Cancer

The landscape of thoracic oncology has undergone a seismic shift over the last 2 decades. Where once a diagnosis of advanced lung cancer offered few paths forward, the advent of precision medicine has transformed the field into one of the most dynamic areas of modern medicine. Bruna Pellini, MD, chief of Thoracic Medical Oncology at Baptist Health Miami Cancer Institute, specializes in treating uncommon mutations and discussed how to navigate the increasingly complex web of targeted therapies.